Promising results provide hope for humans suffering from chronic paralysis
Millions of people worldwide are living with chronic spinal cord injuries, with 250,000 to 500,000 new cases each year—most from vehicle crashes or falls. The most severe spinal cord injuries completely paralyze their victims and more than half impair a person’s ability to breathe. Now, a breakthrough study published in Nature Communications has demonstrated, in animal models of chronic injury, that long-term, devastating effects of spinal cord trauma on breathing and limb function may be reversible.
The new study describes a treatment regimen that helps reawaken certain special types of nerve cells that can regenerate extensions, called axons, within the damaged spinal cord. Rats with spinal cords half severed at the second cervical vertebrae (C2) regained complete diaphragm and partial forelimb function on the severed side after treatment. The recuperative effects of the therapy were fully maintained six months after treatment end.
“For the first time we have permanently restored both breathing and some arm function in a form of high cervical, chronic spinal cord injury-induced paralysis. The complete recovery, especially of breathing, occurs rapidly after a near lifetime of paralysis in a rodent model,” says senior author Jerry Silver, PhD, professor of neurosciences at Case Western Reserve University School of Medicine.
The treatment leverages the body’s innate ability to very slowly sprout new axon branches from a sub-population of nerve cells that remain intact below the injury. The activity of these new branches is completely stifled by a family of potently inhibitory molecules called proteoglycans. Said Silver, “The strategy was to use a simple, one-time injection of an enzyme, chondroitinase, that breaks down the inhibitory proteoglycan molecules. The enzyme was administered, not within the lesion itself, but lower down within the spinal cord where motor nerve cells reside that send axons out to the diaphragm and forearm.”
In animals treated immediately after spinal cord injury, the enzyme only marginally helped restore nerve growth with minimal functional recovery. However, in animals treated long after injury, the therapeutic effects of the enzyme were remarkably better. In as little as one week after treatment in chronically injured rats, new nerve extensions began to restore diaphragm function that had been silent for many months. Seventy percent of rats treated with the enzyme chronically, also began to use their forelimbs to move about and explore their environment (compared to only 30 percent of control animals).
“Surprisingly, the technique worked far better at chronic stages than at acute stages after injury,” says Silver. The longer the animals had been paralyzed, the greater were the restorative effects of the enzyme. Silver’s team found that even after an unprecedented year and a half following spinal cord injury, the treatment could recover full activity to rat diaphragms. One week after treatment, 60 percent of the animals had improved diaphragm function. Two weeks later, every rat showed improvement—even though their paralysis had lasted most of their lives.
Interestingly, exposing the rats to brief periods of low oxygen levels, a respiratory therapy known as acute intermittent hypoxia, helped strengthen the growing nerve extensions, providing an added benefit. However, Silver’s team found that when the rats were treated with the enzyme combined with excessive amounts of respiratory therapy, rats developed chaotic activity in their once paralyzed diaphragms. The researchers hypothesized that the potential for highly abnormal activity may be why the body releases inhibitory molecules to prevent functional axon regeneration in the spinal cord. They are now working to optimize the combination therapy to maximize recovery, especially in the forearm and paw.
“Our data illustrate the relative ease with which an essential motor system can regain functionality months to years after severe spinal cord injury,” says Silver. “The treatment regimen in our study is relevant to multiple types of chronic incomplete spinal traumas, and we are hopeful it may also help restore motor function following spinal cord injury in humans.”
The Latest on: Spinal cord injury
via Google News
The Latest on: Spinal cord injury
- Kennedy Krieger Institute Provides Hope For Spinal Cord Patients With Ski Trip on February 19, 2019 at 3:07 pm
After suffering a spinal cord injury while playing football during his junior year in high school in 2004, Brooks started treatment at the International Center for Spinal Cord Injury at Kennedy ... […]
- Electrical stimulation technique helps patients with spinal cord injury on February 19, 2019 at 2:10 pm
Tom E Nightingale received funding from the Michael Smith Foundation for Health Research in partnership with the International Collaboration On Repair Discoveries (ICORD) (‘Research Trainee ... […]
- The Ted Thompson-era Packers lost several key draft picks far too early to injury on February 19, 2019 at 11:38 am
Carted off the field with a spinal cord injury, the Packers faithful never again saw the blossoming playmaker catch passes from Aaron Rodgers. Unlike some other notable draft picks in the Ted Thompson ... […]
- Spinal Cord Injury Could Throw Off Body’s Internal Clock on February 19, 2019 at 6:41 am
Although paralysis is the most noticeable result of a spinal cord injury, a new study by researchers at The University of Texas (UT) at Austin suggests such injuries could throw off the internal clock ... […]
- Japan Approves iPS Cell Therapy Trial for Spinal Cord Injury on February 18, 2019 at 1:09 pm
The Japanese government’s health ministry has given the go-ahead for a trial of human induced pluripotent stem cells to treat spinal cord injury, Reuters reports today (February 18). Researchers at Ke... […]
- Japan approves test of iPS cells for treating spinal injuries on February 18, 2019 at 12:54 am
The Keio University team headed by professors Hideyuki Okano and Masaya Nakamura will seek four patients, aged 18 or older, who have lost mobility and sensory functions due to a spinal cord injury sus... […]
- Spinal cord stimulator device shows promise in Minneapolis study on February 16, 2019 at 5:00 am
Numerous questions remain, but the findings should lead to an effort to develop strategies "to maximize recovery in all participants with chronic SCI," or spinal-cord injury, the report says. The stud... […]
- RDD Pharma Receives Fast Track Designation from FDA for RDD-0315 for Treatment of Fecal Incontinence in Spinal Cord Injury Patients on February 14, 2019 at 3:00 am
NEW YORK, Feb. 14, 2019 /PRNewswire/ -- RDD Pharma, Inc., a specialty pharmaceutical company focused on development and commercialization of innovative therapeutics for anorectal and lower gastrointes... […]
- BioArctic's Product Candidate SC0806 for Treatment of Patients With Complete Spinal Cord Injury is now in Phase 2 on February 12, 2019 at 11:59 pm
STOCKHOLM, Feb. 13, 2019 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the first patient in the second panel of the Phase 1/2 study now has been treated with ... […]
via Bing News